Cargando…

PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells

The protein kinase C (PKC) signaling, a major regulator of chondrocytic differentiation, has been also implicated in pathological extracellular matrix remodeling, and here we investigate the mechanism of PKCε-dependent regulation of the chondrocytic phenotype in human nucleus pulposus (NP) cells der...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsirimonaki, Emmanouella, Fedonidis, Constantinos, Pneumaticos, Spiros G., Tragas, Adamantios A., Michalopoulos, Ioannis, Mangoura, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842981/
https://www.ncbi.nlm.nih.gov/pubmed/24312401
http://dx.doi.org/10.1371/journal.pone.0082045
_version_ 1782293021166927872
author Tsirimonaki, Emmanouella
Fedonidis, Constantinos
Pneumaticos, Spiros G.
Tragas, Adamantios A.
Michalopoulos, Ioannis
Mangoura, Dimitra
author_facet Tsirimonaki, Emmanouella
Fedonidis, Constantinos
Pneumaticos, Spiros G.
Tragas, Adamantios A.
Michalopoulos, Ioannis
Mangoura, Dimitra
author_sort Tsirimonaki, Emmanouella
collection PubMed
description The protein kinase C (PKC) signaling, a major regulator of chondrocytic differentiation, has been also implicated in pathological extracellular matrix remodeling, and here we investigate the mechanism of PKCε-dependent regulation of the chondrocytic phenotype in human nucleus pulposus (NP) cells derived from herniated disks. NP cells from each donor were successfully propagated for 25+ culture passages, with remarkable tolerance to repeated freeze-and-thaw cycles throughout long-term culturing. More specifically, after an initial downregulation of COL2A1, a stable chondrocytic phenotype was attested by the levels of mRNA expression for aggrecan, biglycan, fibromodulin, and lumican, while higher expression of SOX-trio and Patched-1 witnessed further differentiation potential. NP cells in culture also exhibited a stable molecular profile of PKC isoforms: throughout patient samples and passages, mRNAs for PKC α, δ, ε, ζ, η, ι, and µ were steadily detected, whereas β, γ, and θ were not. Focusing on the signalling of PKCε, an isoform that may confer protection against degeneration, we found that activation with the PKCε-specific activator small peptide ψεRACK led sequentially to a prolonged activation of ERK1/2, increased abundance of the early gene products ATF, CREB1, and Fos with concurrent silencing of transcription for Ki67, and increases in mRNA expression for aggrecan. More importantly, ψεRACK induced upregulation of hsa-miR-377 expression, coupled to decreases in ADAMTS5 and cleaved aggrecan. Therefore, PKCε activation in late passage NP cells may represent a molecular basis for aggrecan availability, as part of an PKCε/ERK/CREB/AP-1-dependent transcriptional program that includes upregulation of both chondrogenic genes and microRNAs. Moreover, this pathway should be considered as a target for understanding the molecular mechanism of IVD degeneration and for therapeutic restoration of degenerated disks.
format Online
Article
Text
id pubmed-3842981
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38429812013-12-05 PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells Tsirimonaki, Emmanouella Fedonidis, Constantinos Pneumaticos, Spiros G. Tragas, Adamantios A. Michalopoulos, Ioannis Mangoura, Dimitra PLoS One Research Article The protein kinase C (PKC) signaling, a major regulator of chondrocytic differentiation, has been also implicated in pathological extracellular matrix remodeling, and here we investigate the mechanism of PKCε-dependent regulation of the chondrocytic phenotype in human nucleus pulposus (NP) cells derived from herniated disks. NP cells from each donor were successfully propagated for 25+ culture passages, with remarkable tolerance to repeated freeze-and-thaw cycles throughout long-term culturing. More specifically, after an initial downregulation of COL2A1, a stable chondrocytic phenotype was attested by the levels of mRNA expression for aggrecan, biglycan, fibromodulin, and lumican, while higher expression of SOX-trio and Patched-1 witnessed further differentiation potential. NP cells in culture also exhibited a stable molecular profile of PKC isoforms: throughout patient samples and passages, mRNAs for PKC α, δ, ε, ζ, η, ι, and µ were steadily detected, whereas β, γ, and θ were not. Focusing on the signalling of PKCε, an isoform that may confer protection against degeneration, we found that activation with the PKCε-specific activator small peptide ψεRACK led sequentially to a prolonged activation of ERK1/2, increased abundance of the early gene products ATF, CREB1, and Fos with concurrent silencing of transcription for Ki67, and increases in mRNA expression for aggrecan. More importantly, ψεRACK induced upregulation of hsa-miR-377 expression, coupled to decreases in ADAMTS5 and cleaved aggrecan. Therefore, PKCε activation in late passage NP cells may represent a molecular basis for aggrecan availability, as part of an PKCε/ERK/CREB/AP-1-dependent transcriptional program that includes upregulation of both chondrogenic genes and microRNAs. Moreover, this pathway should be considered as a target for understanding the molecular mechanism of IVD degeneration and for therapeutic restoration of degenerated disks. Public Library of Science 2013-11-28 /pmc/articles/PMC3842981/ /pubmed/24312401 http://dx.doi.org/10.1371/journal.pone.0082045 Text en © 2013 Tsirimonaki et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Tsirimonaki, Emmanouella
Fedonidis, Constantinos
Pneumaticos, Spiros G.
Tragas, Adamantios A.
Michalopoulos, Ioannis
Mangoura, Dimitra
PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells
title PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells
title_full PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells
title_fullStr PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells
title_full_unstemmed PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells
title_short PKCε Signalling Activates ERK1/2, and Regulates Aggrecan, ADAMTS5, and miR377 Gene Expression in Human Nucleus Pulposus Cells
title_sort pkcε signalling activates erk1/2, and regulates aggrecan, adamts5, and mir377 gene expression in human nucleus pulposus cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842981/
https://www.ncbi.nlm.nih.gov/pubmed/24312401
http://dx.doi.org/10.1371/journal.pone.0082045
work_keys_str_mv AT tsirimonakiemmanouella pkcesignallingactivateserk12andregulatesaggrecanadamts5andmir377geneexpressioninhumannucleuspulposuscells
AT fedonidisconstantinos pkcesignallingactivateserk12andregulatesaggrecanadamts5andmir377geneexpressioninhumannucleuspulposuscells
AT pneumaticosspirosg pkcesignallingactivateserk12andregulatesaggrecanadamts5andmir377geneexpressioninhumannucleuspulposuscells
AT tragasadamantiosa pkcesignallingactivateserk12andregulatesaggrecanadamts5andmir377geneexpressioninhumannucleuspulposuscells
AT michalopoulosioannis pkcesignallingactivateserk12andregulatesaggrecanadamts5andmir377geneexpressioninhumannucleuspulposuscells
AT mangouradimitra pkcesignallingactivateserk12andregulatesaggrecanadamts5andmir377geneexpressioninhumannucleuspulposuscells